BRAF and melanoma: We showed that TRIM16 protein expression by IHC was significantly increased in patient melanoma tissues during early treatment with BRAF inhibitors (p=0.0018, two sided t-test, 95% confidence intervals 0.4 to 1.3) and reduced at relapse (Fig. 5D and 5E).